openPR Logo
Press release

DiGeorge Syndrome Drug Market 2020 Size, Share and Trend Analysis | Top Vendors - AbbVie, Amgen, F. Hoffmann-La Roche, Johnson & Johnson, Angimmune LLC, Karyopharm, Neon Therapeutics, Novartis

DiGeorge Syndrome Drug Market

DiGeorge Syndrome Drug Market

The DiGeorge Syndrome Drug Market report lists and studies the leading competitors, as well as provides the insights with strategic industry analysis of the key factors influencing the market dynamics. In this report, the market is segmented according to type, application, end users, and region. Moreover, it presents granular analysis of the market share, segmentation, revenue forecasts and geographic regions of the market. Each segment and sub-segment is studied carefully to provide a broad segmental analysis of the global DiGeorge Syndrome Drug Market. Such segmental analysis will help clients to focus on high-growth areas of the global market.

Get Sample PDF (including COVID19 Impact Analysis) of Market Report @ https://www.databridgemarketresearch.com/request-a-sample/?dbmr=global-digeorge-syndrome-drug-market&rp

With the use of integrated approaches and latest technology for the best results, DiGeorge Syndrome Drug Market research report is generated. Experienced and innovative industry experts estimate strategic options, figure out winning action plans and help out businesses make critical bottom-line decisions. This market report is a great source of notable data, present market trends, future events, market environment, technological innovation, imminent technologies & the technical development in the Healthcare industry. DiGeorge Syndrome Drug Market report is an excellent resource that provides current as well as upcoming technical & financial details of the industry to 2026.

Market Analysis: Global DiGeorge Syndrome Drug Market

Global DiGeorge syndrome drug market is expected to grow at a substantial CAGR in the forecast period of 2019-2026. Growing incidence of DiGeorge syndrome’s population and development of newer therapies and treatment are the key factors for market growth

Key Market Players: Global DiGeorge Syndrome Drug Market

Few of the major competitors currently working in the global Digeorge syndrome drug market are Aevi Genomic Medicine, Inc, Bausch Health, Natera, Inc, Roche Sequencing, Enzyvant, Progenity, Inc., Boehringer Ingelheim International GmbH, AbbVie Inc., Amgen Inc, F. Hoffmann-La Roche Ltd, Johnson & Johnson Services, Inc, Angimmune LLC, Sumitomo Dainippon Pharma Co., Ltd., CELGENE CORPORATION, CELLECTAR BIOSCIENCES, INC, eFFECTOR Therapeutics, Inc., IMV Inc, Karyopharm, Neon Therapeutics, Novartis AG and many others

Get Full TOC, Tables and Figures of Market Report @ https://www.databridgemarketresearch.com/toc/?dbmr=global-digeorge-syndrome-drug-market&rp

Market Definition: Global DiGeorge Syndrome Drug Market

DiGeorge syndrome is also known as 22q11.2 deletion syndrome or velocardiofacial syndrome is a rare pediatric congenital condition where children are born with absence of chromosome 22. This results to severe immunodeficiency causing poor development of several body systems. Children with DiGeorge syndrome disorders have no ability to fight against infections.

According to the article puplished in Northwestern University, it is estimated that the incident population of DiGeorge Syndrome in the United States around 500 to 750 and over 2.5 million children diagnosed yearly. These growing incidents of DiGeorge syndrome’s population worldwide and robust pipeline for development of newer therapies are the key factors for market growth.

Segmentation: Global DiGeorge Syndrome Drug Market

DiGeorge Syndrome Drug Market : By Therapy Type

Regenerative Medicine Advanced Therapy
Hormone Replacement Therapy

DiGeorge Syndrome Drug Market : By Treatment

Medication
Surgery
Palatoplasty

DiGeorge Syndrome Drug Market : By Route of administration

Oral
Injectable

DiGeorge Syndrome Drug Market : By End Users

Hospitals
Homecare
Specialty Clinics
Others

DiGeorge Syndrome Drug Market : By Geography

North America
South America
Europe
Asia-Pacific
Middle East & Africa

Key Developments in the Market:

In June 2019, Enzyvant’s drug candidate RVT-802, a tissue-based regenerative therapy received the FDA acceptance of Biologic License Application (BLA) as well as Priority Review status for the treatment of pediatric congenital athymia associated with complete DiGeorge Anomaly (cDGA), CHARGE syndrome, and FOXN1 deficiency. If approved, it will be the first drug used for the treatment of DiGeorge syndrome and turning it into a potential blockbuster commercial milestone for Enzyvant.
In September 2017, Enzyvant received Rare Pediatric Disease designation from the FDA for RVT-802, a tissue-based regenerative therapy for treatment of congenital athymia associated with complete DiGeorge Syndrome. The FDA Rare Pediatric Disease designation will enable to receive a rare pediatric disease priority review voucher upon approval of Biologic License Application (BLA).

DiGeorge Syndrome Drug Market Drivers

Vulnerable pediatric population of DiGeorge syndrome
Emergence of drugs for treating serious disease such as CNS disorders and cardiovascular diseases associated with DiGeorge syndrome
Increase in the rate of R&D initiatives is driving  DiGeorge syndrome therapeutics market

DiGeorge Syndrome Drug Market Restraints

Effective treatment is either unavailable or unaffordable
Patent expiry from many companies and introduction of generic drugs of branded version is expected to restrain the growth if the market
Inadequate knowledge about DiGeorge syndrome in some developing countries

Reasons to Purchase this Report :

Current and future of global Digeorge syndrome drug market outlook in the developed and emerging markets
The segment that is expected to dominate the market as well as the segment which holds highest CAGR in the forecast period
Regions/Countries that are expected to witness the fastest growth rates during the forecast period
The latest developments, market shares, and strategies that are employed by the major market players

Do You Have Any Query Or Specific Requirement? Ask to Our Industry Expert @ https://www.databridgemarketresearch.com/inquire-before-buying/?dbmr=global-digeorge-syndrome-drug-market&rp

Contact Us
Data Bridge Market Research
US: +1 888 387 2818
UK: +44 208 089 1725
Hong Kong: +852 8192 7475
Mail: Corporatesales@databridgemarketresearch.com
https://databridgemarketresearch.com

About Data Bridge Market Research :

Data Bridge Market Research is a versatile market research and consulting firm with over 500 analysts working in different industries. We have catered more than 40% of the fortune 500 companies globally and have a network of more than 5000+ clientele around the globe. Our coverage of industries include Medical Devices, Pharmaceuticals, Biotechnology, Semiconductors, Machinery, Information and Communication Technology, Automobiles and Automotive, Chemical and Material, Packaging, Food and Beverages, Cosmetics, Specialty Chemicals, Fast Moving Consumer Goods, Robotics, among many others.

Data Bridge adepts in creating satisfied clients who reckon upon our services and rely on our hard work with certitude. We are content with our glorious 99.9 % client satisfying rate.

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release DiGeorge Syndrome Drug Market 2020 Size, Share and Trend Analysis | Top Vendors - AbbVie, Amgen, F. Hoffmann-La Roche, Johnson & Johnson, Angimmune LLC, Karyopharm, Neon Therapeutics, Novartis here

News-ID: 2072884 • Views:

More Releases from Data Bridge Market Research Pvt. Ltd.

The Digital Landscape: Examining the Surge in Media Monitoring Software Market Valuation to USD 7584.77 Million by 2029 with a Striking CAGR of 14.40
The Digital Landscape: Examining the Surge in Media Monitoring Software Market V …
For an excellent business growth, companies must take up market research report service which is imperative in today's market place. "Media Monitoring Software Market" research report has been produced with a nice blend of industry insight, smart and practical solutions and newest technology to endow with the better user experience. The report brings into focus several aspects related to industry and market. A few of these can be listed here
Animal Antibiotics Antimicrobials Market Sales to Top USD 6.3 billion by 2029
Animal Antibiotics Antimicrobials Market Sales to Top USD 6.3 billion by 2029
Antimicrobials are substances that kill or inhibit the majority of germs. The antimicrobials can be natural, semi-synthetic, or synthetic. Antibiotics are all antimicrobials, but antimicrobials aren't all antibiotics. Antibiotics are basically used to treat clinical illness, prevent and manage common disease occurrences, and improve animal development and growth. They are used in food animals in three ways: therapeutic, prophylactic, and sub-therapeutic. Antimicrobials offer significant advantages in terms of animal
Benzene Market Research 2021-2028: China National Petroleum Corporation, Haldia …
Market research reports help business or organization in every sphere of trade to take better decisions, to respond the toughest business questions and reduce the risk of failure. In the world class Benzene market report, data collection modules with large sample sizes are used to collect data and perform base year analysis. The market research data included in this report is analysed and forecasted using market statistical and coherent models.
Digital Inks Market Report 2021-2027: Cabot Corporation, INX International Ink C …
Digital Inks Market research reports are very influential in many ways to grow the business. Digital Inks market report is a superior and comprehensive market research report which endows professionals with a lot of aspects about the market and the industry. The marketing report presents market potential for each geographical region based on the growth rate, macroeconomic parameters, consumer buying patterns, their preferences for particular product and market demand and

All 5 Releases


More Releases for DiGeorge

Global DiGeorge Syndrome Drug Market Report Forecast to 2021-2027 |key players a …
The chromosome 22 abnormality causes DiGeorge syndrome, which is a chromosomal condition. DiGeorge syndrome causes delays in the development of various body systems, as well as cardiac problems, impaired immunological function, a cleft palate, and low calcium levels in the blood. Clinics, patients, and other clinical benefits are available to enterprises associated with the DiGeorge Syndrome Drug Market industry. These organizations that provide clinical protection have become necessary and chosen support
DiGeorge Syndrome Drug Market Share, Trends, Future Scope, Forecast 2026| Aevi G …
The in-depth research report on DiGeorge Syndrome Drug Market added to its huge repository by DBMR provides imprehensive and all aspects of market research. The market insights of this market report helps with the successful launch of new product. The report efficiently gathers, analyzes and interprets information about a market, about a product or service to be offered for sale in that market. Potential customers for the product or service and
DiGeorge Syndrome Drug Market 2020 Share Analysis By Aevi Genomic Medicine, Inc, …
DiGeorge syndrome drug market is expected to grow at a substantial CAGR in the forecast period of 2019-2026. Growing incidence of DiGeorge syndrome’s population and the development of newer therapies and treatment are the key factors for market growth. Global DiGeorge Syndrome Drug Market By Therapy Type (Regenerative Medicine Advanced Therapy and Hormone Replacement Therapy), Treatment Type (Medication and Surgery), Route of Administration (Oral and Injectable), End- Users (Hospitals, Homecare, Specialty
DiGeorge Syndrome Drug Market 2020 Future Outlook | Key Players - Aevi Genomic M …
The primary sources employed while generating this DiGeorge Syndrome Drug Market report include the industry experts from the industry comprising the management corporation, processing organizations, analytical service suppliers of the industry's value chain. All primary sources are interviewed to accumulate the data and validate qualitative & quantitative information and conclude future prospects. Secondary research consists of key data about the industry value chain, the complete pool of major players, and
DiGeorge Syndrome Drug Market Worth Observing Growth : CELLECTAR BIOSCIENCES, IN …
The DiGeorge Syndrome Drug Market analysis report brings into focus studies about market definition, market segmentation, and competitive analysis in the market. The precise and state-of-the-art information provided via this report helps businesses get aware about the types of consumers, consumer's demands and preferences, their point of view about the product, their buying intentions, their response to particular product, and their varying tastes about the specific product already existing in
DiGeorge Syndrome Drug Market Upcoming Scope and Challenges 2026| Aevi Genomic M …
Data Bridge Market Research has added an exhaustive research study of the Global DiGeorge Syndrome Drug Market detailing every single market driver and intricately analyzing the business vertical. The research report has abilities to rise as the most significant market worldwide as it has remained to play a remarkable role in establishing progressive impacts on the universal economy. The Research report presents a complete assessment of the Market and contains